Infliximab treatment for anal fistula in patients with crohn's disease

Anticancer Research

Volumn 29, Issue 3, 2009, Pages 927-934

  Higashi, Daijiro ^a   Futami, Kitaro ^a   Egawa, Yuji ^a   Hirano, Kennji ^a   Tomiyasu, Takashige ^a   Ishibashi, Yukiko ^a   Simomura, Tamotsu ^a   Nil, Kaori ^a   Kuroki, Hirosuke ^a   Maekawa, Takafumi ^a   Ono, Yoichiro ^a   Matsui, Toshiyuki ^a  

^a Fukuoka University Chikushi Hospital   (Japan)

Author keywords

Anal fistula; Crohn's disease; Infliximab

Indexed keywords

INFLIXIMAB;

ADULT; ANUS FISTULA; CLINICAL EVALUATION; CONFERENCE PAPER; CROHN DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DISEASE COURSE; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT RESPONSE;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; COMBINED MODALITY THERAPY; CROHN DISEASE; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; HUMANS; INFLAMMATION; MALE; PROGNOSIS; QUALITY OF LIFE; RECTAL FISTULA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 64949187912     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. Agnholt J, Dahlerup F, Buntzen S et al: Response, relapse and mucosal immune regulation after infliximab treatment in fistulating Crohn's disease. Aliment Pharmacol Ther 17: 703-710,2003.
2. Sands BE, Anderson FH, Bernstein CN et al: Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med 350: 876-885, 2004.
3. Assche GV, Vanbeckevoort D, Bielen D et al: Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease. Am J Gastroenterol 98: 332-339, 2003.
4. Domenech E, Hinojosa J. Nos P et al: Clinical evolution of luminal and perianal Crohn's disease after inducing remission with infliximab: how long should patients be treated? Aliment Pharmacol Ther 22: 1107-1113, 2005.
5. Yamana T, Makita K and Iwadare J: MRI diagnosis of pelvorectal fistulas. J Jpn Soc Coloproctol 55: 799-806, 2002 (in Japanese).
6. Rasul I, Wilson SR, MacRae H et al: Clinical and radiological responses after infliximab treatment for perianal fistulizing Crohn's disease. Am J Gastroenterol 99: 82-88, 2004.
7. Bell SJ, Halligan S, Windsor ACJ et al: Response of fistulating Crohn's disease to infliximab treatment assessed by magnetic resonance imaging. Aliment Pharmacol Ther 17: 387-393, 2003.
8. Regueiro M and Mardini H: Treatment of perianal fistulizing Crohn's disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement. Inflamm Bowel Dis 9: 98-103,2003.
9. Cadahia V, Garcia-Carbonero A, Vivas S et al: Infliximab improves quality of life in the short-term in patients with fistulizing Crohn's disease in clinical practice. Rev Esp Enferm Dig 96: 369-378, 2004.
10. Ardizzone S, Maconi G, Colombo E et al: Perianal fistulae following infliximab treatment. Inflamm Bowel Dis 10: 91-96, 2004.
11. Poupardin C, Lemann M, Gendre J et al: Efficacy of infliximab in Crohn's disease. Gastroenterol Clin Biol 30: 247-252, 2006.
12. Parsi MA, Lashner BA, Achkar J et al: Type of fistula determines response to infliximab in patients with fistulous Crohn's disease. Am J Gastroenterol 99: 445-449, 2004.
13. Topstad DR, Panaccione R, Heine J Art al: Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease. Dis Colon Rectum 46: 577-583, 2003.
14. Hagen SJ, Baeten CG, Soeters PB et al: Anti-TNF-α (infliximab) used as induction treatment in case of active proctitis in a multistep strategy followed by definitive surgery of complex anal fistulas in Crohn's disease. Dis Colon Rectum 48: 758-767,2005.
15. Talbot C, Sagar PM, Johnston M J et al: Infliximab in the surgical management of complex fistulating anal Crohn's disease. Colorectal Dis 7: 164-168, 2005.
16. Gaertner WB, Decanini A, Mellgren A et al: Dose infliximab infusion impact results of operative treatment for Crohn's perianal fistulas? Dis Colon Rectum 50: 1754-1760, 2007.
17. West RL, van der Woude CJ, Hansen B E et al: Clinical and endosonographic effect of ciprofloxacin on the treatment of perianal fistulae in Crohn's disease with infliximab: a double-blind placebo-controlled study. Aliment Pharmacol Ther 20: 1329-1336,2004.
18. Luna-Chadid M, Perz Calle JL, Mendoza JL et al: Predictors of response to infliximab in patients with fistulizing Crohn's disease. Rev Esp Enferm Dig 96: 379-384, 2003.
19. Poritz LS: How should complex perianal Crohn's disease be treated in the Remicade era? J Gasrointest Surg 10: 633-634, 2006.
20. Biancone L, Orlando A, Kohn A et al: Infliximab and newly diagnosed neoplasia in Crohn's disease: a multicentre matched pair study. Gut 55: 228-233, 2006.